Cystic Fibrosis is a genetic illness that affects the lungs and digestive systems of 30,000 adults and children in the United States today.To combat this statistic,a local father created and just today launched a phone app to help him ...
Tags: Cystic Fibrosis, genetic illness, phone app, Jason Phipps
Pulmatrix, a developer of inhalable drug delivery platforms, has appointed Robert Clarke as the company's new chief executive officer (CEO). Previously, Clarke served as the company's chief scientific officer and vice president of ...
The European Commission has approved Vertex Pharmaceuticals' Kalydeco (ivacaftor) to treat the underlying cause of cystic fibrosis in people with a specific genetic mutation (G551D). The approval is based on positive findings from two ...
Tags: european approval, kalydeco, cystic fibrosis
Driven by a requirement to store e-mail correspondence in an electronic day file, Cystic Fibrosis Trust has implemented CommVault Simpana file and e-mail archiving software. The Cystic Fibrosis Trust is the UK's only national charity ...
Tags: Cystic Fibrosis Trust, e-mail archiving software, CommVault Simpana file
The European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Vertex Pharmaceuticals' Kalydeco (ivacaftor) to treat the underlying cause of cystic fibrosis (CF). Kalydeco is indicated for people ...
Tags: Kalydeco, cystic fibrosis, clinical study
Digestive Care (DCI) has gained FDA approval for its new drug application (NDA) for Pertzye, a pancreatic enzyme product containing bicarbonate-buffered enteric-coated microspheres. Pertzye is indicated for the treatment of Exocrine ...